Recently, we showed that GSK-3 contributes to the maintenance of active chromatin at NF-κB target gene Bcl-2 and XIAP promoters, allowing p65 binding and transcriptional activation in cancer cells (Ougolkov et al, 2007). Here, NFKB1 is linked to cancer.